In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Knowing the facts can help you make safer and smarter health decisions
due to NDMA (cancer causing carcinogen) impurities
Best For Men seeking weight loss and appetite support Method Prescription GLP-1 injection Frequency Typically once weekly Coverage under extended health benefit plans varies by provider and policy
The order also covers amendments, verification, and a deficiency and dispute resolution process
Dulaglutide : This medication has the shortest room temperature window at just 14 days